This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Urologix Announces Election Of Patrick D. Spangler As Director

Urologix®, Inc. (NASDAQ: ULGX), a medical device company that develops, manufactures and markets minimally invasive Cooled ThermoTherapy™ technology to urologists to provide a durable and effective in-office treatment for patients suffering from benign prostatic hyperplasia (BPH), announced Patrick D. Spangler has joined the Board of Directors effective August 15, 2010.

“Pat brings to our Board a wealth of business experience and expertise, as well as a deep understanding of medical device companies,” stated Stryker Warren Jr., CEO. “His strong background in the successful development and execution of strategic plans, business development functions, and public and private capital raising transactions enhances the diverse skill sets of our current Board members and is certain to be important to the future of Urologix.”

Mr. Spangler has spent over 23 years in the medical field including senior management roles with ev3, Empi, Inc. and Medtronic, Inc. where he has fulfilled CFO and treasury responsibilities. Pat received his BS degree in accounting and his Masters of Business degree in taxation from the University of Minnesota, and his MBA from the University of Chicago.

Mr. Spangler stated, “I am delighted to be joining the Board of Urologix, a leader in nonsurgical solutions for benign prostatic hyperplasia (BPH). As the population of aging, male baby boomers continues to grow, nonsurgical and non-pharmacological solutions will make up an ever increasing proportion of the treatment options for BPH.”

About Urologix

Urologix, Inc., based in Minneapolis, MN develops, manufactures and markets minimally invasive medical products for the treatment of urological disorders. The Company has developed and offers nonsurgical, anesthesia-free, catheter-based treatments that use a proprietary cooled microwave technology for the treatment of benign prostatic hyperplasia (BPH), a condition that affects more than 23 million men worldwide. Urologix' products include the CoolWave®, Targis® and Prostatron® control units and the CTC Advance™, Cooled ThermoCath®, Targis® and Prostaprobe® catheter families. All of Urologix' products utilize Cooled ThermoTherapy™ - targeted microwave energy combined with a unique cooling mechanism to protect healthy tissue and enhance patient comfort - and provide safe, effective, lasting relief of the symptoms of BPH.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
ULGX $0.02 -3.85%
AAPL $118.09 -0.18%
FB $105.50 1.20%
GOOG $758.06 2.10%
TSLA $231.96 0.74%


Chart of I:DJI
DOW 17,790.58 +70.66 0.40%
S&P 500 2,088.85 +8.44 0.41%
NASDAQ 5,124.1650 +15.4990 0.30%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs